Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.109784
Revised: June 28, 2025
Accepted: October 13, 2025
Published online: March 20, 2026
Processing time: 265 Days and 6.3 Hours
Advancements in 3D printing technologies have significantly transformed osteochondral tissue engineering, enabling the creation of scaffolds that closely mimic the structural and biological complexities of native tissue. These scaffolds provide a 3D environment conducive to cellular adhesion, proliferation, and dif
To explore the feasibility of 3D printed scaffolds in osteochondral applications, highlights innovative materials and techniques, and addresses the existing knowledge gaps and challenges in clinical translation.
This scoping review adhered to PRISMA extension for scoping reviews guidelines to systematically map innovations in 3D printed bio-scaffolds for osteochondral tissue engineering. Due to heterogeneous data, it favored a scoping over syste
The fabrication of biomimetic scaffolds, incorporating bioactive elements such as growth factors, has shown promise in replicating the extracellular matrix and enhancing tissue regeneration. Cutting-edge techniques, including inkjet, extrusion-based, and laser-assisted bioprinting, allow precise spatial control and multi-material integration essential for osteochondral scaffolds. Innovations such as graded scaffolds and bio-inks enriched with nanoparticles have further improved scaffold functionality, mechanical stability, and biological activity. Despite these advancements, limitations persist, including material challenges in achieving the desired balance of bioactivity, biodegradability, and mechanical properties. Fabrication methods face issues of scalability, reproducibility, and resolution, while the long-term biological interactions between scaffolds and host tissues, particularly degradation products, remain underexplored. Regulatory and economic barriers also impede clinical translation, underscoring the need for collaborative research efforts. Future directions emphasize the potential of emerging technologies, such as 4D printing, smart biomaterials, and soundwave patterning, to address current challenges and unlock new opportunities.
The convergence of biomaterial science, additive manufacturing, and regenerative medicine holds immense promise for advancing personalized treatments and revolutionizing osteochondral tissue engineering.
Core Tip: Advancements in 3D printing have revolutionized osteochondral tissue engineering by enabling biomimetic scaffolds that replicate native tissue complexities. These scaffolds support cellular adhesion, proliferation, and differentiation while maintaining mechanical integrity and biodegradability. Innovative techniques, such as laser-assisted bioprinting and bio-inks enriched with nanoparticles, enhance functionality and regeneration. However, challenges persist in scalability, reproducibility, and clinical translation. Future directions, including 4D printing and smart biomaterials, offer promising solutions for personalized treatments.
